Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Garodia Chemical Ltd

GARODCH
BSE
10.67
Last Updated:
27 Jan '26, 3:58 PM
Company Overview
Alert
Watchlist
Note

Garodia Chemical Ltd

GARODCH
BSE
10.67
27 Jan '26, 3:58 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
8Cr
Close
Close Price
10.67
Industry
Industry
Trading
PE
Price To Earnings
2.01
PS
Price To Sales
Revenue
Revenue
0Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM
-2,005.00%
Peer Comparison
How does GARODCH stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
GARODCH
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
Other Income
Other IncomeCr
000000000040
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000040
Tax
TaxCr
000000000000
PAT
PATCr
000000000040
Growth YoY
PAT Growth YoY%
33.3-400.00.0-300.0-50.080.0-1,000.0-25.0-300.0-500.03,754.640.0
NPM
NPM%
EPS
EPS
0.0-0.10.0-0.10.00.0-0.2-0.1-0.2-0.15.60.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
000000000000
Growth
Revenue Growth%
Expenses
ExpensesCr
000001000000
Operating Profit
Operating ProfitCr
00000-1000000
OPM
OPM%
Other Income
Other IncomeCr
000400000004
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-26030-1000004
Tax
TaxCr
000000000000
PAT
PATCr
-26030-1000004
Growth
PAT Growth%
-939.6414.3-103.81,593.1-106.0-239.174.141.541.6-118.6-58.41,934.7
NPM
NPM%
EPS
EPS
-2.68.1-0.34.6-0.3-0.9-0.2-0.1-0.1-0.2-0.35.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
777777777777
Reserves
ReservesCr
-19-13-14-10-11-11-11-12-12-12-12-8
Current Liabilities
Current LiabilitiesCr
1180000000000
Non Current Liabilities
Non Current LiabilitiesCr
307434444551
Total Liabilities
Total LiabilitiesCr
211100000000
Current Assets
Current AssetsCr
000100000000
Non Current Assets
Non Current AssetsCr
211000000000
Total Assets
Total AssetsCr
211100000000

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-100-10-100000
Investing Cash Flow
Investing Cash FlowCr
00040000000
Financing Cash Flow
Financing Cash FlowCr
100-40100000
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
-10040-100000
CFO To PAT
CFO To PAT%
36.9-2.049.4-19.8-180.787.391.5123.455.9124.5137.4
CFO To EBITDA
CFO To EBITDA%
1,046.053.999.7453.1-180.787.391.5123.455.9124.4137.4

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
000000047710
Price To Earnings
Price To Earnings
0.00.00.00.00.00.00.00.00.00.00.0
Price To Sales
Price To Sales
Price To Book
Price To Book
0.00.00.00.00.00.00.0-0.9-1.6-1.5-2.0
EV To EBITDA
EV To EBITDA
-128.1-33.6-66.3-26.2-17.1-5.9-23.8-79.2-186.4-87.0-69.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
NPM
NPM%
ROCE
ROCE%
50.1593.3-25.9506.3-229.0-1,122.01,173.6-1,091.6346.8-853.2-170.8
ROE
ROE%
15.3-93.23.4-105.76.016.94.22.41.42.94.4
ROA
ROA%
-94.9399.5-16.7495.8-185.5-405.9-164.8-96.2-93.9-203.4-148.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
**Garodia Chemicals Limited** is an Indian **MSME** (Udyam Registration No. **UDYAM-MH19-0002293**) historically specialized in the manufacturing and trading of **dyes, chemicals, and chemical byproducts**. After a prolonged period of operational suspension and financial distress, the company is currently undergoing a comprehensive structural and financial revival following a court-approved **Resolution Plan** under the **Insolvency and Bankruptcy Code (IBC)**. --- ### 1. Current Corporate Status & Insolvency Resolution The company’s recent history is defined by its transition from a **Corporate Debtor** to a revitalized entity. Following intense competition from the **China Market** and sustained losses, the company ceased operations, leading to a **Pre-packaged Insolvency Resolution Process (PPIRP)**. * **NCLT Approval:** The **Hon’ble NCLT, Mumbai Bench**, approved the **Base Resolution Plan (BRP)** on **February 24, 2025**. * **Resolution Applicant:** The plan was submitted jointly by the company and **Mr. Ravindra Subhash Salunkhe** (the Successful Resolution Applicant). * **Monitoring Committee:** A committee was constituted on **May 28, 2025**, to oversee the implementation of the BRP and ensure compliance with the transition milestones. * **Going Concern Status:** While financial statements for **FY 2024-25** were prepared on a **Non-Going Concern** basis (with assets/liabilities carried at **Fair Value**), the implementation of the BRP aims to restore commercial viability. --- ### 2. Capital Reconstitution & Shareholding Reset To address the total erosion of net worth and settle creditor claims, the company is executing a significant restructuring of its equity base. | Action Item | Impact on Shareholding | Key Date | | :--- | :--- | :--- | | **Promoter Extinguishment** | Full cancellation of **3,728,800** shares (**51.79%** stake) held by former promoters without payment. | **Dec 10, 2025** | | **Public Consolidation** | Existing public shareholders receive **1** new share for every **13** shares held. | **Dec 10, 2025** | | **Stock Sub-division** | Reduction of Face Value (FV) from **Rs. 10** to **Re. 1** per share. | **Mar 25, 2026** | | **Authorized Capital** | Maintained at **INR 11,00,00,000** (1.10 Cr shares). | Current | | **Paid-up Capital** | **INR 7,20,02,000** (Pre-restructuring). | Current | --- ### 3. New Governance Framework & Management Under the approved BRP, the previous management (Mahesh Gordhandas Garodia, Kunal Nalin Naik, and Brian Lawrence Fernandes) has resigned, making way for a new leadership team appointed by the Resolution Applicant. * **Managing Director:** **Mr. Ravindra Subhash Salunkhe** (Appointed for a 5-year term effective **March 10, 2025**, to **March 09, 2030**). * **Board Reconstitution:** * **Mrs. Bhagyashri Nilesh Devrale** (Non-Executive Non-Independent Director). * **Mr. Vikram Ravindra Sabnis** (Independent Director). * **Internal Controls:** The company is establishing a new framework including a **Risk Management policy** and an **Internal Audit System** to review **Standard Operating Procedures (SOPs)**. --- ### 4. Financial Performance & Debt Resolution The company has reported **zero operating revenue** since **April 2019**. Recent financial statements reflect the costs of the insolvency process and the settlement of legacy liabilities. **Standalone Financial Summary:** | Metric (INR) | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Revenue** | **0** | **75** | **0** | | **Profit After Tax (Loss)** | **(20,76,622)** | **(13,10,909)** | **(5,99,716)** | | **Dividend** | **Nil** | **Nil** | **Nil** | **Debt Profile (as of NCLT Filings):** * **Total Financial Debt:** **Rs. 4,41,21,594**. * **Related Party Debt:** **Rs. 4,10,40,598** (Owed to former Director Mr. Mahesh Garodia). * **Unrelated Financial Debt:** **Rs. 9,00,528** (Owed to M/s WZ Enterprises Private Limited). * **Settlement Status:** Recent "Other Income" entries reflect the settlement of loans from former promoters and **M/s Garodia Sons Private Limited** as per the NCLT-approved plan. --- ### 5. Operational Restart Strategy The primary objective of the new management is to leverage the company’s **MSME status** and historical industry classification to resume manufacturing. * **Asset Profile:** Currently, the company has **Nil Fixed Assets** (no plant or machinery). The Resolution Applicant is responsible for infusing capital to acquire necessary infrastructure. * **Core Focus:** Resumption of **chemical and chemical product manufacturing**. * **Financial Projections:** The BRP includes specific projections (detailed in **Exhibit D** of the plan) intended to restore the company to profitability through new business activities. --- ### 6. Critical Risk Factors & Audit Qualifications Investors should note significant historical lapses and ongoing risks identified by statutory auditors: * **Material Uncertainty:** Auditors have previously expressed doubt regarding the company's ability to meet liabilities falling due within one year. * **Internal Control Deficiencies:** * Lack of an **Internal Audit System** commensurate with company size. * Inability of auditors to conclude on the effectiveness of **Internal Financial Controls Over Financial Reporting (ICFR)**. * Absence of third-party confirmations for **sundry creditors, debtors, and loans**. * **Regulatory Non-Compliance:** Historical failures to appoint a **Women Director**, **CFO**, or **Internal Auditor**, and failure to maintain a **Structured Digital Database** under SEBI (PIT) Regulations. * **Takeover Exemptions:** While the NCLT initially raised concerns regarding **SEBI Takeover Regulations**, the **NCLAT** clarified that the resolution plan is exempt from certain mandatory tender offer obligations under the IBC framework. * **Subsidiaries:** The company has **no subsidiaries, associates, or joint ventures**, simplifying the corporate structure for the turnaround.